SOME FORMULATION FACTORS INFLUENCING THE RATE OF DRUG RELEASE FROM BIOADHESIVE MATRICES

被引:18
作者
SMART, JD
机构
[1] The School of Pharmacy and Biomedical Sciences, Portsmouth Polytechnic, Portsmouth
关键词
D O I
10.3109/03639049209043695
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The development of monolithic matrices with controlled release and mucosa-adhesive properties was investigated. After an initial screening procedure for formulations that showed stability and minimal swelling, the rate of release of a model water soluble drug from various polyacrylic acid containing matrices was evaluated. All the formulations gave a prolonged drug release relative to a lactose containing control formulation. A formulation containing Carbopol 934P and CaCl2 was found to give the slowest rate of drug release (t50% of 7.77h), with release kinetics nearest to the ideal zero order. When tested in a modified tensiometer it was found that the inclusion of a relatively high loading of a model drug did not adversely affect the adhesive properties of these formulations.
引用
收藏
页码:223 / 232
页数:10
相关论文
共 14 条
[1]  
Chen J. L., 1970, ADHESION BIOL SYSTEM, P163, DOI DOI 10.1016/B978-0-12-469050-9.50015-6
[2]   BIOADHESIVE POLYMERS AS PLATFORMS FOR ORAL CONTROLLED DRUG DELIVERY .2. SYNTHESIS AND EVALUATION OF SOME SWELLING, WATER-INSOLUBLE BIOADHESIVE POLYMERS [J].
CHNG, HS ;
PARK, H ;
KELLY, P ;
ROBINSON, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (04) :399-405
[3]  
GU JM, 1988, CRC CR REV THER DRUG, V5, P21
[4]  
GURSOY A, 1989, STP PHARM, V5, P886
[5]  
Harris D, 1989, STP PHARM, V5, P852
[6]  
LAW TK, 1985, J PHARM PHARMACOL, V37, pP67
[7]   BIOADHESIVE TABLETS INFLUENCE OF THE TESTING MEDIUM COMPOSITION ON BIOADHESION [J].
LEJOYEUX, F ;
PONCHEL, G ;
WOUESSIDJEWE, D ;
PEPPAS, NA ;
DUCHENE, D .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (12) :2037-2048
[8]  
NAGAI T, 1987, Journal of Controlled Release, V6, P353, DOI 10.1016/0168-3659(87)90088-5
[9]   TOPICAL MUCOSAL ADHESIVE DOSAGE FORMS [J].
NAGAI, T .
MEDICINAL RESEARCH REVIEWS, 1986, 6 (02) :227-242
[10]  
Robinson JR, 1989, STP PHARMA, V5, P838